Slade Mike, Bird Victoria, Clarke Eleanor, Le Boutillier Clair, McCrone Paul, Macpherson Rob, Pesola Francesca, Wallace Genevieve, Williams Julie, Leamy Mary
King's College London, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, Denmark Hill, London, UK.
King's College London, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, Denmark Hill, London, UK.
Lancet Psychiatry. 2015 Jun;2(6):503-14. doi: 10.1016/S2215-0366(15)00086-3. Epub 2015 May 27.
Mental health policy in many countries is oriented around recovery, but the evidence base for service-level recovery-promotion interventions is lacking.
We did a cluster, randomised, controlled trial in two National Health Service Trusts in England. REFOCUS is a 1-year team-level intervention targeting staff behaviour to increase focus on values, preferences, strengths, and goals of patients with psychosis, and staff-patient relationships, through coaching and partnership. Between April, 2011, and May, 2012, community-based adult mental health teams were randomly allocated to provide usual treatment plus REFOCUS or usual treatment alone (control). Baseline and 1-year follow-up outcomes were assessed in randomly selected patients. The primary outcome was recovery and was assessed with the Questionnaire about Processes of Recovery (QPR). We also calculated overall service costs. We used multiple imputation to estimate missing data, and the imputation model captured clustering at the team level. Analysis was by intention to treat. This trial is registered, number ISRCTN02507940.
14 teams were included in the REFOCUS group and 13 in the control group. Outcomes were assessed in 403 patients (88% of the target sample) at baseline and in 297 at 1 year. Mean QPR total scores did not differ between the two groups (REFOCUS group 40·6 [SD 10·1] vs control 40·0 [10·2], adjusted difference 0·68, 95% CI -1·7 to 3·1, p=0·58). High team participation was associated with higher staff-rated scores for recovery-promotion behaviour change (adjusted difference -0·4, 95% CI -0·7 to -0·2, p=0·001) and patient-rated QPR interpersonal scores (-1·6, -2·7 to -0·5, p=0·005) at follow-up than low participation. Patients treated in the REFOCUS group incurred £1062 (95% CI -1103 to 3017) lower adjusted costs than those in the control group.
Although the primary endpoint was negative, supporting recovery might, from the staff perspective, improve functioning and reduce needs. Implementation of REFOCUS could increase staff recovery-promotion behaviours and improve patient-rated recovery.
National Institute for Health Research.
许多国家的心理健康政策都围绕康复展开,但缺乏服务层面促进康复干预措施的证据基础。
我们在英国的两个国民健康服务信托基金中进行了一项整群随机对照试验。REFOCUS是一项为期1年的团队层面干预措施,旨在通过辅导和合作,针对工作人员的行为,以增加对精神病患者的价值观、偏好、优势和目标以及工作人员与患者关系的关注。在2011年4月至2012年5月期间,将社区成人心理健康团队随机分配为提供常规治疗加REFOCUS或仅提供常规治疗(对照组)。在随机选择的患者中评估基线和1年随访结果。主要结局是康复,并使用康复过程问卷(QPR)进行评估。我们还计算了总体服务成本。我们使用多重插补来估计缺失数据,插补模型考虑了团队层面的聚类情况。分析采用意向性分析。该试验已注册,注册号为ISRCTN02507940。
REFOCUS组纳入14个团队,对照组纳入13个团队。在基线时对403名患者(占目标样本的88%)进行了结局评估,1年时对297名患者进行了评估。两组的QPR总分均值无差异(REFOCUS组为40.6[标准差10.1],对照组为40.0[10.2],调整差异为0.68,95%置信区间为-1.7至3.1,p=0.58)。与低参与度相比,高团队参与度与随访时工作人员评定的促进康复行为改变得分较高(调整差异为-0.4,95%置信区间为-0.7至-0.2,p=0.001)以及患者评定的QPR人际得分较高(-1.6,-2.7至-0.5,p=0.005)相关。REFOCUS组治疗的患者比对照组患者的调整成本低1062英镑(95%置信区间为-1103至3017)。
尽管主要终点为阴性,但从工作人员的角度来看,支持康复可能会改善功能并减少需求。实施REFOCUS可以增加工作人员促进康复的行为,并改善患者评定的康复情况。
英国国家卫生研究院。